Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 12

Serotypes, antibiotic susceptibility and whole-genome characterization of in Sichuan Province, China in 2023 Open Access

Abstract

. is a leading cause of pneumonia, meningitis and other invasive diseases. The increasing prevalence of antibiotic resistance in has become a major public health concern, complicating clinical treatment and highlighting the need for continuous surveillance.

. Although previous studies have reported the antimicrobial resistance, serotype distribution and molecular characteristics of in some regions of China, systematic and whole-genome sequencing-based epidemiological data for Sichuan Province remain limited. Currently, there is a lack of comprehensive understanding regarding the predominant serotypes, resistance profiles, virulence gene carriage and their relationship with global clonal complexes in this region. In particular, data supporting the assessment of vaccine-covered serotypes and the transmission risk of multidrug-resistant strains are insufficient.

. This study aimed to investigate the prevalence, serotype distribution, antimicrobial resistance and molecular characteristics of isolates in Sichuan Province, providing genomic evidence to support rational antibiotic use and optimize immunization strategies.

. A total of 105 clinical strains were collected in 2023 through the China Pathogen Identification Net. The serotypes, molecular types and antibiotic resistance of the strains were determined by whole-genome sequencing, sequence analysis and antimicrobial susceptibility test.

. The leading serotypes were 19F (34.29%), 19A (10.48%), 3(7.62%) and 6E (7.62%). The dominant sequence types (STs) were ST271 (30.48%) and ST320 (10.48%), with CC271 and GPSC1 being the predominant groups. Vaccine coverage rates were 45.71% for PCV7/PCV10, 64.76% for PCV13, 69.52% for PCV20 and 70.48% for PPV23. All isolates were susceptible to linezolid and vancomycin, but high resistance was observed to erythromycin (92.38%), clindamycin (82.86%), tetracycline (86.87%) and trimethoprim/sulfamethoxazole (60.95%). The multidrug resistance (MDR) rate was 85.71%. Nine resistance genes were identified, with ) and ) being the most prevalent.

. Our study provides reliable information, including the prevalence, molecular characterization and antimicrobial resistance of isolates in Sichuan Province of China in 2023. The high MDR rate and predominance of vaccine-covered serotypes highlight the urgent need for enhanced surveillance, rational antibiotic use and broader implementation of pneumococcal vaccines, including the potential introduction of PCV20.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antibiotic susceptibility , molecular characterization , serotype , Streptococcus pneumoniae and whole-genome sequencing
Funding
This study was supported by the:
  • Sichuan Science and Technology Program (Award No. 2022ZDZX0017)
    • Principal Award Recipient: NotApplicable
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.002107
2025-12-18
2026-01-16

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/12/jmm002107.html?itemId=/content/journal/jmm/10.1099/jmm.0.002107&mimeType=html&fmt=ahah

References

  1. Henriques-Normark B, Tuomanen EI. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med 2013; 3:a010215 [View Article] [PubMed]
     [Google Scholar]
  2. Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med 2014; 371:1619–1628 [View Article] [PubMed]
     [Google Scholar]
  3. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:1151–1210 [View Article]
     [Google Scholar]
  4. Wang B, Lin W, Qian C, Zhang Y, Zhao G et al. Disease Burden of Meningitis Caused by Streptococcus pneumoniae Among Under-Fives in China: A Systematic Review and Meta-analysis. Infect Dis Ther 2023; 12:2567–2580 [View Article] [PubMed]
     [Google Scholar]
  5. Rodrigo C, Lim WS. The relevance of pneumococcal serotypes. Curr Infect Dis Rep 2014; 16:403 [View Article] [PubMed]
     [Google Scholar]
  6. Li Y, Wang S, Hong L, Xin L, Wang F et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in China among children under 14 years of age post-implementation of the PCV13: a systematic review and meta-analysis (2017-2024). Pneumonia 2024; 16:18 [View Article] [PubMed]
     [Google Scholar]
  7. Li X-X, Xiao S-Z, Gu F-F, Zhao S-Y, Xie Q et al. Serotype distribution, antimicrobial susceptibility, and multilocus sequencing type (MLST) of Streptococcus pneumoniae from adults of three hospitals in Shanghai, China. Front Cell Infect Microbiol 2019; 9:407 [View Article]
     [Google Scholar]
  8. Chapman TJ, Olarte L, Dbaibo G, Houston AM, Tamms G et al. PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children. Expert Rev Vaccines 2024; 23:137–147 [View Article] [PubMed]
     [Google Scholar]
  9. Briles DE, Paton JC, Mukerji R, Swiatlo E, Crain MJ. Pneumococcal vaccines. Microbiol Spectr 2019; 7: [View Article] [PubMed]
     [Google Scholar]
  10. Weinberger DM, Warren JL, Dalby T, Shapiro ED, Valentiner-Branth P et al. Differences in the impact of pneumococcal serotype replacement in individuals with and without underlying medical conditions. Clin Infect Dis 2019; 69:100–106 [View Article] [PubMed]
     [Google Scholar]
  11. Nurhonen M, Auranen K. Optimal serotype compositions for pneumococcal conjugate vaccination under serotype replacement. PLoS Comput Biol 2014; 10:e1003477 [View Article] [PubMed]
     [Google Scholar]
  12. Ajulo S, Awosile B. Global antimicrobial resistance and use surveillance system (GLASS 2022): investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries. PLoS One 2024; 19:e0297921 [View Article] [PubMed]
     [Google Scholar]
  13. World Health Organization WHO bacterial priority pathogens list; 2024
  14. Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet 2024; 404:1199–1226 [View Article]
     [Google Scholar]
  15. Luo R, Liu B, Xie Y, Li Z, Huang W et al. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience 2012; 1:18 [View Article] [PubMed]
     [Google Scholar]
  16. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article] [PubMed]
     [Google Scholar]
  17. Simpson JT, Wong K, Jackman SD, Schein JE, Jones SJM et al. ABySS: a parallel assembler for short read sequence data. Genome Res 2009; 19:1117–1123 [View Article] [PubMed]
     [Google Scholar]
  18. Lin S-H, Liao Y-C. CISA: contig integrator for sequence assembly of bacterial genomes. PLoS One 2013; 8:e60843 [View Article]
     [Google Scholar]
  19. Sheppard CL, Manna S, Groves N, Litt DJ, Amin-Chowdhury Z et al. PneumoKITy: A fast, flexible, specific, and sensitive tool for Streptococcus pneumoniae serotype screening and mixed serotype detection from genome sequence data. Microb Genom 2022; 8:mgen000904 [View Article] [PubMed]
     [Google Scholar]
  20. Epping L, van Tonder AJ, Gladstone RA, Bentley SD, Page AJ et al. Corrigendum: SeroBA: rapid high-throughput serotyping of Streptococcus pneumoniae from whole genome sequence data. Microb Genom 2018; 4:e000186 [View Article] [PubMed]
     [Google Scholar]
  21. Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 2018; 3:124 [View Article] [PubMed]
     [Google Scholar]
  22. Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol 2020; 37:1530–1534 [View Article] [PubMed]
     [Google Scholar]
  23. Letunic I, Bork P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res 2024; 52:W78–W82 [View Article] [PubMed]
     [Google Scholar]
  24. Ruan Z, Feng Y. BacWGSTdb, a database for genotyping and source tracking bacterial pathogens. Nucleic Acids Res 2016; 44:D682–7 [View Article] [PubMed]
     [Google Scholar]
  25. Feng Y, Zou S, Chen H, Yu Y, Ruan Z. BacWGSTdb 2.0: a one-stop repository for bacterial whole-genome sequence typing and source tracking. Nucleic Acids Res 2021; 49:D644–D650 [View Article]
     [Google Scholar]
  26. Ruan Z, Yu Y, Feng Y. The global dissemination of bacterial infections necessitates the study of reverse genomic epidemiology. Brief Bioinform 2020; 21:741–750 [View Article] [PubMed]
     [Google Scholar]
  27. Lourenço J, Daon Y, Gori A, Obolski U. Pneumococcal competition modulates antibiotic resistance in the pre-vaccination era: a modelling study. Vaccines 2021; 9:265 [View Article] [PubMed]
     [Google Scholar]
  28. Karcic E, Aljicevic M, Bektas S, Karcic B. Antimicrobial susceptibility/resistance of Streptococcus pneumoniae. Mater Sociomed 2015; 27:180–184 [View Article] [PubMed]
     [Google Scholar]
  29. Watkins ER, Kalizang’Oma A, Gori A, Gupta S, Heyderman RS. Factors affecting antimicrobial resistance in Streptococcus pneumoniae following vaccination introduction. Trends Microbiol 2022; 30:1135–1145 [View Article] [PubMed]
     [Google Scholar]
  30. Fang C, Chen XJ, Zhou MM, Chen YH, Zhao RZ et al. Clinical characteristics and antimicrobial resistance of pneumococcal infections from 9 children’s hospitals in 2016. Zhonghua Er Ke Za Zhi 2018; 56:582–586 [View Article] [PubMed]
     [Google Scholar]
  31. Huang X, Ying L, Zhang X, Zhang J, Long S et al. 2017 surveillance of bacterial resistance in Sichuan province. Chin J Antibiot 2018; 43:1143–1150
     [Google Scholar]
  32. Wang Y, Cao Y, Jia Z, He B, Sun Y. Drug resistance gene and virulence gene carriage of the children infected invasive Streptococcus pneumoniae. Chin Trop Med 2022; 22: [View Article]
     [Google Scholar]
  33. He J. The current situation and characteristics of bacterial resistance in China. World Latest Med Inf 2017; 17:
     [Google Scholar]
  34. Montanari MP, Cochetti I, Mingoia M, Varaldo PE. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 2003; 47:2236–2241 [View Article] [PubMed]
     [Google Scholar]
  35. Zhao W, Pan F, Wang B, Wang C, Sun Y et al. Epidemiology characteristics of Streptococcus pneumoniae from children with pneumonia in Shanghai: a retrospective study. Front Cell Infect Microbiol 2019; 9:258 [View Article] [PubMed]
     [Google Scholar]
  36. Zhang Q, Lv Y, Wang S, Wang L, Ma H et al. Investigation of resistant genes and virulence genes of Streptococcus pneumonia. Chin J Nosocomiol 201723
     [Google Scholar]
  37. Huang L-D, Yang M-J, Huang Y-Y, Jiang K-Y, Yan J et al. Molecular characterization of predominant serotypes, drug resistance, and virulence genes of Streptococcus pneumoniae isolates from East China. Front Microbiol 2022; 13:892364 [View Article] [PubMed]
     [Google Scholar]
  38. Dong Y, Huang W, Luo T, Zhang C, Wu L. Prevalence of virulence genes in Streptococcus pneumoniae strains isolated from clinical patients. Chin J Microbiol Immunol 2009; 29:177–180
     [Google Scholar]
  39. Wang Y, Cai P, Jiang X, Wang C, Mi Z. Prevalence of virulence genes in Streptococcus pneumoniae strains isolated from clinical patients and its clinical research. Chin J Nosocomiol 2016; 8:3
     [Google Scholar]
  40. Romero P, López R, García E. Key role of amino acid residues in the dimerization and catalytic activation of the autolysin LytA, an important virulence factor in Streptococcus pneumoniae. J Biol Chem 2007; 282:17729–17737 [View Article] [PubMed]
     [Google Scholar]
  41. Salha D, Szeto J, Myers L, Claus C, Sheung A et al. Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury. Infect Immun 2012; 80:2212–2220 [View Article] [PubMed]
     [Google Scholar]
  42. Johnston JW, Myers LE, Ochs MM, Benjamin WH, Briles DE et al. Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide. Infect Immun 2004; 72:5858–5867 [View Article] [PubMed]
     [Google Scholar]
  43. Wu K, Zhang X, Shi J, Li N, Li D et al. Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae infections in mice. Infect Immun 2010; 78:1276–1283 [View Article] [PubMed]
     [Google Scholar]
  44. Su N, Han X, Yang YM, Lin JT. Distribution characteristics of serotypes of invasive pneumococcal disease in Chinese mainland children. Zhonghua Yi Xue Za Zhi 2016; 96:1465–1469 [View Article] [PubMed]
     [Google Scholar]
  45. Tang P, Du Q, Zeng H, Yuan L, Gao W et al. Serotype and drug resistance of 192 isolates of Streptococcus pneumoniae: a study in Zhongjiang County People’s Hospital, Sichuan. Dis Surveill 2021; 36:147–151
     [Google Scholar]
  46. Zeng Y, Song Y, Cui L, Wu Q, Wang C et al. Phylogenomic insights into evolutionary trajectories of multidrug resistant S. pneumoniae CC271 over a period of 14 years in China. Genome Med 2023; 15:46 [View Article] [PubMed]
     [Google Scholar]
  47. Liu L, Zhang Z, Zhang X, Xu C, Song Y et al. Coverage of 13-valent pneumococcal conjugate vaccine among children 0–15 months of age – 9 provinces, China, 2019–2021. China CDC Wkly 2019; 5:
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.002107
Loading
Serotypes, antibiotic susceptibility and whole-genome characterization of Streptococcus pneumoniae in Sichuan Province, China in 2023
J. Med. Microbiol. 74, 002107 (2025); https://doi.org/10.1099/jmm.0.002107
/content/journal/jmm/10.1099/jmm.0.002107
/content/journal/jmm/10.1099/jmm.0.002107
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error